Header Logo

Connection

THOMAS GIORDANO to Antiretroviral Therapy, Highly Active

Back to Details
This is a "connection" page, showing publications THOMAS GIORDANO has written about Antiretroviral Therapy, Highly Active.
THOMAS GIORDANO
Connection Strength
3.054
Antiretroviral Therapy, Highly Active
  1. Time above 1500 copies: a viral load measure for assessing transmission risk of HIV-positive patients in care. AIDS. 2015 May 15; 29(8):947-54.
    View in: PubMed
    Score: 0.434
  2. Social support as a predictor of early diagnosis, linkage, retention, and adherence to HIV care: results from the steps study. J Assoc Nurses AIDS Care. 2014 Sep-Oct; 25(5):405-13.
    View in: PubMed
    Score: 0.397
  3. Impact of antiretroviral dosing frequency and pill burden on adherence among newly diagnosed, antiretroviral-naive HIV patients. Int J STD AIDS. 2012 May; 23(5):351-5.
    View in: PubMed
    Score: 0.351
  4. The population effectiveness of highly active antiretroviral therapy: are good drugs good enough? Curr HIV/AIDS Rep. 2005 Nov; 2(4):177-83.
    View in: PubMed
    Score: 0.224
  5. Patients referred to an urban HIV clinic frequently fail to establish care: factors predicting failure. AIDS Care. 2005 Aug; 17(6):773-83.
    View in: PubMed
    Score: 0.220
  6. Factors associated with the use of highly active antiretroviral therapy in patients newly entering care in an urban clinic. J Acquir Immune Defic Syndr. 2003 Apr 01; 32(4):399-405.
    View in: PubMed
    Score: 0.187
  7. Implementation and operational research: the impact of option B+ on the antenatal PMTCT cascade in Lilongwe, Malawi. J Acquir Immune Defic Syndr. 2015 Apr 15; 68(5):e77-83.
    View in: PubMed
    Score: 0.108
  8. Examining the link between patient satisfaction and adherence to HIV care: a structural equation model. PLoS One. 2013; 8(1):e54729.
    View in: PubMed
    Score: 0.092
  9. Development and validation of a measure for intention to adhere to HIV treatment. AIDS Patient Care STDS. 2012 Jun; 26(6):329-34.
    View in: PubMed
    Score: 0.088
  10. The spectrum of engagement in HIV care: do more than 19% of HIV-infected persons in the US have undetectable viral load? Clin Infect Dis. 2011 Dec; 53(11):1168-9; author's reply 1169-70.
    View in: PubMed
    Score: 0.084
  11. Communication strategies to improve HIV treatment adherence. Health Commun. 2011 Jul-Aug; 26(5):461-7.
    View in: PubMed
    Score: 0.083
  12. From access to engagement: measuring retention in outpatient HIV clinical care. AIDS Patient Care STDS. 2010 Oct; 24(10):607-13.
    View in: PubMed
    Score: 0.079
  13. Clinical evidence of interaction between itraconazole and nonnucleoside reverse transcriptase inhibitors in HIV-infected patients with disseminated histoplasmosis. Ann Pharmacother. 2009 May; 43(5):908-13.
    View in: PubMed
    Score: 0.071
  14. Accessing antiretroviral therapy following release from prison. JAMA. 2009 Feb 25; 301(8):848-57.
    View in: PubMed
    Score: 0.070
  15. Conspiracy beliefs about HIV infection are common but not associated with delayed diagnosis or adherence to care. AIDS Patient Care STDS. 2008 Sep; 22(9):753-9.
    View in: PubMed
    Score: 0.068
  16. Human immunodeficiency virus-associated squamous cell cancer of the anus: epidemiology and outcomes in the highly active antiretroviral therapy era. J Clin Oncol. 2008 Jan 20; 26(3):474-9.
    View in: PubMed
    Score: 0.065
  17. Care for HIV infection in the US: can we do better? Res Initiat Treat Action. 2007; 12(2):5-7.
    View in: PubMed
    Score: 0.061
  18. Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy. AIDS. 2005 Mar 04; 19(4):399-406.
    View in: PubMed
    Score: 0.053
  19. Hepatitis C coinfection increases the risk of fulminant hepatic failure in patients with HIV in the HAART era. J Hepatol. 2005 Mar; 42(3):309-14.
    View in: PubMed
    Score: 0.053
  20. Cirrhosis and hepatocellular carcinoma in HIV-infected veterans with and without the hepatitis C virus: a cohort study, 1992-2001. Arch Intern Med. 2004 Nov 22; 164(21):2349-54.
    View in: PubMed
    Score: 0.052
  21. Utilization of health care resources by HIV-infected white, African-American, and Hispanic men in the era before highly active antiretroviral therapy. J Natl Med Assoc. 2003 Sep; 95(9):853-61.
    View in: PubMed
    Score: 0.048
  22. Do sex and race/ethnicity influence CD4 cell response in patients who achieve virologic suppression during antiretroviral therapy? Clin Infect Dis. 2003 Aug 01; 37(3):433-7.
    View in: PubMed
    Score: 0.048
  23. Beyond core indicators of retention in HIV care: missed clinic visits are independently associated with all-cause mortality. Clin Infect Dis. 2014 Nov 15; 59(10):1471-9.
    View in: PubMed
    Score: 0.026
  24. Intention to adhere to HIV treatment: a patient-centred predictor of antiretroviral adherence. HIV Med. 2013 Sep; 14(8):472-80.
    View in: PubMed
    Score: 0.023
  25. Time for oncologists to opt in for routine opt-out HIV testing? JAMA. 2010 Jul 21; 304(3):334-9.
    View in: PubMed
    Score: 0.019
  26. Predictors of reincarceration and disease progression among released HIV-infected inmates. AIDS Patient Care STDS. 2010 Jun; 24(6):389-94.
    View in: PubMed
    Score: 0.019
  27. Screening HIV-infected individuals for anal cancer precursor lesions: a systematic review. Clin Infect Dis. 2006 Jul 15; 43(2):223-33.
    View in: PubMed
    Score: 0.015
  28. Survival in hepatitis C and HIV co-infection: a cohort study of hospitalized veterans. Clin Gastroenterol Hepatol. 2005 Feb; 3(2):175-83.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.